Samuel Blackman: As many of you know, I do like to write things

Samuel Blackman, Founder and Head of Research and Development at Day One Biopharmaceuticals, shared on LinkedIn:

“As many of you know, I do like to write things. And on the occasion of our recent approval, I had some thoughts.

It took a while for me to get them out as last week was a whirlwind of emotion and meetings and travel and celebration.

But I finally did. Instead of putting them in print, however, I decided to just say them (warning: this may exceed the MTD of Sam for most people).

Finally, for everyone who sent a lovely note, thank you. I read every single one.”

Proceed to video attached to post.
Source: Samuel Blackman/LinkedIn